Live temperature-sensitive equine influenza virus vaccine: generation of the virus and efficacy in hamsters.
Temperature-sensitive (ts) reassortants of an equine influenza virus, subtype A-1, were produced by mating a human influenza ts donor virus with an equine influenza A/Cornell/16/74 wild-type virus and by isolating a ts reassortant virus possessing the equine hemagglutinin and neuraminidase surface antigens. Two equine its reassortant clones, 8B1 and 71A1, were produced which had an in vitro shutoff temperature for plaque formation of 38 and 37 C, respectively. The human ts donor virus had ts mutation(s) on the polymerase 3 (P3) and nucleoprotein genes so that a ts equine reassortant virus could have either or both of these ts genes. It was found by complementation analysis that reassortant clone 8B1 had a ts lesion on the P3 gene and clone 71A1 had ts lesions on the nucleoprotein and P3 genes. An analysis of the parental origin of the genes in each ts equine reassortant virus indicated that clone 8B1 received 6 of its 8 genes and clone 71A1, 3 of its 8 from the equine parent virus, the remainder genes being from the human ts donor virus. The growth of both clones was restricted in the lungs of hamsters, but similar to that of the equine wild-type virus in the nasal turbinates. Each virus isolate obtained from the hamster's lungs or nasal turbinates retained the ts phenotype. These findings form the basis for further evaluation of the equine ts reassortant viruses for their level of attenuation and immunogenicity in horses.
D000818:Animals; D006224:Cricetinae / Q000382:microbiology*; D004274:DNA, Recombinant; D004591:Electrophoresis, Polyacrylamide Gel; D005816:Genetic Complementation Test; D005838:Genotype; D009980:Influenza A virus / Q000235:genetics / Q000254:growth & development* / Q000302:isolation & purification; D008168:Lung / Q000382:microbiology; D008647:Mesocricetus / Q000382:microbiology*; D012367:RNA, Viral / Q000302:isolation & purification; D013696:Temperature; D010948:Viral Plaque Assay; D014765:Viral Vaccines / Q000302:isolation & purification*
D004274:DNA, Recombinant; D012367:RNA, Viral; D014765:Viral Vaccines